The forkhead transcription factor, FOXP3, is required for normal pituitary gonadotropin expression in mice

Biology of Reproduction

Volumn 86, Issue 5, 2012, Pages

  Jung, Deborah O ^a   Jasurda, Jake S ^a   Egashira, Noboru ^b   Ellsworth, Buffy S ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Forkhead; FOXP3; Gonadotropins; Pituitary

Indexed keywords

CORTICOTROPIN; EARLY GROWTH RESPONSE FACTOR 1; FOLLITROPIN BETA SUBUNIT; GONADOTROPIN; LUTEINIZING HORMONE BETA SUBUNIT; MESSENGER RNA; PROLACTIN; PROOPIOMELANOCORTIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR LHX3; TRANSCRIPTION FACTOR PITX1; TRANSCRIPTION FACTOR PITX2; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; GONADORELIN; GONADORELIN RECEPTOR; THYROTROPIN BETA SUBUNIT;

ALPHA CHAIN; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; HYPOGONADOTROPIC HYPOGONADISM; HYPOPHYSIS; HYPOTHALAMUS; IMMUNOCOMPETENT CELL; LOSS OF FUNCTION MUTATION; MALE; MALE INFERTILITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID GLAND; THYROIDITIS; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DRUG EFFECT; DRUG POTENTIATION; GENETICS; HYPOGONADISM; METABOLISM; MOUSE MUTANT;

MUS;

ANIMALS; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT; FORKHEAD TRANSCRIPTION FACTORS; GONADOTROPIN-RELEASING HORMONE; HYPOGONADISM; HYPOTHALAMUS; INFERTILITY, MALE; LUTEINIZING HORMONE, BETA SUBUNIT; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PITUITARY GLAND; PRO-OPIOMELANOCORTIN; PROLACTIN; RECEPTORS, LHRH; THYROTROPIN, BETA SUBUNIT; TRANSCRIPTION FACTORS;

EID: 84864016284     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.111.094904     Document Type: Article

References (58)

1. Genuth SM. Physiology. St. Louis, MO: Mosby Year Book; 1993.
2. Conti M, Andersen CB, Richard FJ, Shitsukawa K, Tsafriri A. Role of cyclic nucleotide phosphodiesterases in resumption of meiosis. Mol Cell Endocrinol 1998; 145:9-14.
3. Richards JS, Russell DL, Robker RL, Dajee M, Alliston TN. Molecular mechanisms of ovulation and luteinization. Mol Cell Endocrinol 1998; 145:47-54.
4. Jorgensen JS, Quirk CC, Nilson JH. Multiple and overlapping combinatorial codes orchestrate hormonal responsiveness and dictate cell-specific expression of the genes encoding luteinizing hormone. Endocr Rev 2004; 25:521-542.
5. Brugh VM III, Lipshultz LI. Male factor infertility: evaluation and management. Med Clin North Am 2004; 88:367-385.
6. Nachtigall RD. International disparities in access to infertility services. Fertil Steril 2006; 85:871-875.
7. Huhtaniemi I, Zhang FP, Kero J, Hamalainen T, Poutanen M. Transgenic and knockout mouse models for the study of luteinizing hormone and luteinizing hormone receptor function. Mol Cell Endocrinol 2002; 187: 49-56.
8. Wijchers PJ, Burbach JP, Smidt MP. In control of biology: of mice, men and Foxes. Biochem J 2006; 397:233-246.
9. Li B, Greene MI. FOXP3 actively represses transcription by recruiting the HAT/HDAC complex. Cell Cycle 2007; 6:1432-1436.
10. Powell BR, Buist NR, Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 1982; 100: 731-737.
11. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-1061.
12. Chen GY, Chen C, Wang L, Chang X, Zheng P, Liu Y. Cutting edge: broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells. J Immunol 2008; 180:5163-5166.
13. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D, Ziegler SF, Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001; 27:68-73.
14. Lyon MF. Hypogonadism in scurfy (sf) males. Mouse News Lett 1986; 74:93.
15. Godfrey VL, Wilkinson JE, Rinchik EM, Russell LB. Fatal lymphoreticular disease in the scurfy (sf) mouse requires T cells that mature in a sf thymic environment: potential model for thymic education. Proc Natl Acad Sci U S A 1991; 88:5528-5532.
16. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-408.
17. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3:1101-1108.
18. Duval DL, Farris AR, Quirk CC, Nett TM, Hamernik DL, Clay CM. Responsiveness of the ovine gonadotropin-releasing hormone receptor gene to estradiol and gonadotropin-releasing hormone is not detectable in vitro but is revealed in transgenic mice. Endocrinology 2000; 141: 1001-1010.
19. van der Vliet HJ, Nieuwenhuis EE. IPEX as a result of mutations in FOXP3. Clin Dev Immunol 2007; 2007:89017.
20. Wolfe MW, Call GB. Early growth response protein 1 binds to the luteinizing hormone-beta promoter and mediates gonadotropin-releasing hormone-stimulated gene expression. Mol Endocrinol 1999; 13:752-763.
21. Halvorson LM, Ito M, Jameson JL, Chin WW. Steroidogenic factor-1 and early growth response protein 1 act through two composite DNA binding sites to regulate luteinizing hormone beta-subunit gene expression. J Biol Chem 1998; 273:14712-14720.
22. Tremblay JJ, Drouin J. Egr-1 is a downstream effector of GnRH and synergizes by direct interaction with Ptx1 and SF-1 to enhance luteinizing hormone beta gene transcription. Mol Cell Biol 1999; 19:2567-2576.
23. Quirk CC, Lozada KL, Keri RA, Nilson JH. A single Pitx1 binding site is essential for activity of the LHbeta promoter in transgenic mice. Mol Endocrinol 2001; 15:734-746.
24. Gage PJ, Suh H, Camper SA. Dosage requirement of Pitx2 for development of multiple organs. Development 1999; 126:4643-4651.
25. Suh H, Gage PJ, Drouin J, Camper SA. Pitx2 is required at multiple stages of pituitary organogenesis: pituitary primordium formation and cell specification. Development 2002; 129:329-337.
26. Ellsworth BS, Butts DL, Camper SA. Mechanisms underlying pituitary hypoplasia and failed cell specification in Lhx3-deficient mice. Dev Biol 2008; 313:118-129.
27. Sheng HZ, Zhadanov AB, Mosinger B Jr, Fujii T, Bertuzzi S, Grinberg A, Lee EJ, Huang SP, Mahon KA, Westphal H. Specification of pituitary cell lineages by the LIM homeobox gene Lhx3. Science 1996; 272: 1004-1007.
28. Ellsworth BS, Burns AT, Escudero KW, Duval DL, Nelson SE, Clay CM. The gonadotropin releasing hormone (GnRH) receptor activating sequence (GRAS) is a composite regulatory element that interacts with multiple classes of transcription factors including Smads, AP-1 and a forkhead DNA binding protein. Mol Cell Endocrinol 2003; 206:93-111.
29. Ellsworth BS, Egashira N, Haller JL, Butts DL, Cocquet J, Clay CM, Osamura RY, Camper SA. FOXL2 in the pituitary: molecular, genetic, and developmental analysis. Mol Endocrinol 2006; 20:2796-2805.
30. Coss D, Mellon PL, Thackray VG. A FoxL in the Smad house: activin regulation of FSH. Trends Endocrinol Metab 2010; 21:562-568.
31. Tran S, Lamba P, Wang Y, Bernard DJ. SMADs and FOXL2 synergistically regulate murine FSHbeta transcription via a conserved proximal promoter element. Mol Endocrinol 2011; 25:1170-1183.
32. Justice NJ, Blount AL, Pelosi E, Schlessinger D, Vale W, Bilezikjian LM. Impaired FSHfbetag expression in the pituitaries of Foxl2 mutant animals. Mol Endocrinol 2011; 25:1404-1415.
33. Lahl K, Loddenkemper C, Drouin C, Freyer J, Arnason J, Eberl G, Hamann A, Wagner H, Huehn J, Sparwasser T. Selective depletion of Foxp3{Thorn} regulatory T cells induces a scurfy-like disease. J Exp Med 2007; 204:57-63.
34. Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol 2006; 24: 209-226.
35. Ochs HD, Gambineri E, Torgerson TR. IPEX, FOXP3 and regulatory Tcells: a model for autoimmunity. Immunol Res 2007; 38:112-121.
36. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, Levy- Lahad E, Mazzella M, Goulet O, Perroni L, Bricarelli FD, Byrne G, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001; 27: 18-20.
37. Sharma R, Deshmukh US, Zheng L, Fu SM, Ju ST. X-linked Foxp3 (Scurfy) mutation dominantly inhibits submandibular gland development and inflammation respectively through adaptive and innate immune mechanisms. J Immunol 2009; 183:3212-3218.
38. Brothers KJ, Wu S, DiVall SA, Messmer MR, Kahn CR, Miller RS, Radovick S, Wondisford FE, Wolfe A. Rescue of obesity-induced infertility in female mice due to a pituitary-specific knockout of the insulin receptor. Cell Metab 2010; 12:295-305.
39. Wildin RS, Freitas A. IPEX and FOXP3: clinical and research perspectives. J Autoimmun 2005; 25(suppl): 56-62.
40. Jannini EA, Ulisse S, D'Armiento M. Thyroid hormone and male gonadal function. Endocr Rev 1995; 16:443-459.
41. Lin W, Truong N, Grossman WJ, Haribhai D, Williams CB, Wang J, Martin MG, Chatila TA. Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice. J Allergy Clin Immunol 2005; 116: 1106-1115.
42. Wu S, Wolfe A. Signaling of cytokines is important in regulation of GnRH neurons. Mol Neurobiol 2012; 45:119-125.
43. Savino W, Arzt E, Dardenne M. Immunoneuroendocrine connectivity: the paradigm of the thymus-hypothalamus/pituitary axis. Neuroimmunomodulation 1999; 6:126-136.
44. Gaillard RC, Turnill D, Sappino P, Muller AF. Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors. Endocrinology 1990; 127:101-106.
45. Charlton HM, Halpin DM, Iddon C, Rosie R, Levy G, McDowell IF, Megson A, Morris JF, Bramwell A, Speight A, Ward BJ, Broadhead J, et al. The effects of daily administration of single and multiple injections of gonadotropin-releasing hormone on pituitary and gonadal function in the hypogonadal (hpg) mouse. Endocrinology 1983; 113:535-544.
46. Hamernik DL, Nett TM. Gonadotropin-releasing hormone increases the amount of messenger ribonucleic acid for gonadotropins in ovariectomized ewes after hypothalamic-pituitary disconnection. Endocrinology 1988; 122:959-966.
47. Spratt DI, Crowley WF Jr. Pituitary and gonadal responsiveness is enhanced during GnRH-induced puberty. Am J Physiol 1988; 254: E652-657.
48. Gharib SD, Wierman ME, Shupnik MA, Chin WW. Molecular biology of the pituitary gonadotropins. Endocr Rev 1990; 11:177-199.
49. Mason AJ, Hayflick JS, Zoeller RT, Young WS III, Phillips HS, Nikolics K, Seeburg PH. A deletion truncating the gonadotropin-releasing hormone gene is responsible for hypogonadism in the hpg mouse. Science 1986; 234:1366-1371.
50. McCue JM, Quirk CC, Nelson SE, Bowen RA, Clay CM. Expression of a murine gonadotropin-releasing hormone receptor-luciferase fusion gene in transgenic mice is diminished by immunoneutralization of gonadotropinreleasing hormone. Endocrinology 1997; 138:3154-3160.
51. Clayton RN, Channabasavaiah K, Stewart JM, Catt KJ. Hypothalamic regulation of pituitary gonadotropin-releasing hormone receptors: effects of hypothalamic lesions and a gonadotropin-releasing hormone antagonist. Endocrinology 1982; 110:1108-1115.
52. Hubert FX, Kinkel SA, Crewther PE, Cannon PZ, Webster KE, Link M, Uibo R, O'Bryan MK, Meager A, Forehan SP, Smyth GK, Mittaz L, et al. Aire-deficient C57BL/6 mice mimicking the common human 13-base pair deletion mutation present with only a mild autoimmune phenotype. J Immunol 2009; 182:3902-3918.
53. Pelletier RM, Yoon SR, Akpovi CD, Silvas E, Vitale ML. Defects in the regulatory clearance mechanisms favor the breakdown of self-tolerance during spontaneous autoimmune orchitis. Am J Physiol Regul Integr Comp Physiol 2009; 296:R743-R762.
54. Maier CC, Marchetti B, LeBoeuf RD, Blalock JE. Thymocytes express a mRNA that is identical to hypothalamic luteinizing hormone-releasing hormone mRNA. Cell Mol Neurobiol 1992; 12:447-454.
55. Marchetti B, Gallo F, Farinella Z, Tirolo C, Testa N, Caniglia S, Morale MC. Gender, neuroendocrine-immune interactions and neuron-glial plasticity. Role of luteinizing hormone-releasing hormone (LHRH). Ann N Y Acad Sci 2000; 917:678-709.
56. Morale MC, Gallo F, Tirolo C, L'Episcopo F, Gennuso F, Testa N, Caniglia S, Spina-Purrello V, Avola R, Scoto GM, Marchetti B. The reproductive system at the neuroendocrine-immune interface: focus on LHRH, estrogens and growth factors in LHRH neuron-glial interactions. Domest Anim Endocrinol 2003; 25:21-46.
57. Goya RG, Console GM, Sosa YE, Gomez Dumm CL, Dardenne M. Altered functional responses with preserved morphology of gonadotrophic cells in congenitally athymic mice. Brain Behav Immun 2001; 15:85-92.
58. Camihort G, Luna G, Vesenbeckh S, Ferese C, Dardenne M, Goya R, Console G. Morphometric assessment of the impact of serum thymulin immunoneutralization on pituitary cell populations in peripubertal mice. Cells Tissues Organs 2006; 184:23-30.